"10.1371_journal.pone.0045666","plos one","2012-09-19T00:00:00Z","Andrea Bravi; Geoffrey Green; Andr√© Longtin; Andrew J E Seely","Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada; Therapeutic Monitoring Systems Inc., Ottawa, Ontario, Canada; Department of Physics, University of Ottawa, Ottawa, Ontario, Canada; Division of Thoracic Surgery, University of Ottawa, Ottawa, Ontario, Canada; Department of Critical Care Medicine, University of Ottawa, Ottawa, Ontario, Canada","Conceived and designed the experiments: AB GG AL AJES. Analyzed the data: AB. Wrote the paper: AB.","The authors have read the journals policy and have the following conflicts: Andrew J.E. Seely is founder and Chief Science Officer of Therapeutic Monitoring Systems, Inc. (TMS), created to commercialize patented Continuous Individualized Multi-organ Variability Analysis (CIMVA) technology, with the objective of delivering variability-directed clinical decision support to improve quality and efficiency of care. Geoffrey C. Green is currently employed by TMS in the position of Product Manager. All the other authors have declared that no competing interests exist. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","09","Andrea Bravi","AB",4,FALSE,4,NA,1,1,TRUE,TRUE,FALSE,0,NA,FALSE
